SEC EDGAR Filing Information

Form SC 13D -- General statement of acquisition of beneficial ownership

Filing Date Changed: 2009-02-20
Documents: 1

SEC Accession No.
0000950162-09-000089
Filing date: 2009-02-20
Accepted: 2009-02-20 14:09:54

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D	sigmataupharm13d_021109.htm	236538	DOR BIOPHARMA/SIGMA TAU PHARMACEUTICALS SCHEDULE 13D - 02/11/09

		0000950162-09-000089.txt	238672	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 09624552
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

Sigma-Tau Pharmaceuticals, Inc. (Filed by) (0001385625)
IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D | Act: | Film No.:

Business Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877
1-800-447-0169

Mailing Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877